Lin Shen
Impact in
- Gastroenterology top 0.1%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 255
- Colorectal Cancer Treatments and Studies 83
- Cancer Immunotherapy and Biomarkers 70
- Pancreatic and Hepatic Oncology Research 33
- HER2/EGFR in Cancer Research 29
-
- Gastric Cancer Management and Outcomes 100
- Lung Cancer Treatments and Mutations 44
- Co-authors
- Yoon‐Koo Kang (13 shared papers)Atsushi Ohtsu (10 shared papers)Hyun Cheol Chung (6 shared papers)Yung‐Jue Bang (6 shared papers)Eric Van Cutsem (13 shared papers)Akira Sawaki (2 shared papers)Taroh Satoh (3 shared papers)A. Feyereislova (1 shared paper)
- Journals
- Journal of Clinical Oncology (135 papers)Annals of Oncology (45 papers)BMC Cancer (9 papers)Future Oncology (9 papers)Cancer Research (9 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Lin Shen
458 papers receiving 15.6k citations
Lin Shen's Hit Papers
Peers
Comparison fields: 5 of 162
- Gastroenterology 1.6k
- Oncology 5.7k
- Pulmonary and Respiratory Medicine 5.0k
- Cancer Research 1.6k
- Surgery 3.1k
Countries citing papers authored by Lin Shen
This map shows the geographic impact of Lin Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Shen more than expected).
Fields of papers citing papers by Lin Shen
This network shows the impact of papers produced by Lin Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Shen. The network helps show where Lin Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 487 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Hit paper breakdown → | 2010 | 5344 |
| 2 | Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells Hit paper breakdown → | 2020 | 982 |
| 3 | Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study Hit paper breakdown → | 2013 | 382 |
| 4 | Fifteen-Year Effects of Helicobacter pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and Mortality Hit paper breakdown → | 2012 | 347 |
| 5 | Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study Hit paper breakdown → | 2018 | 344 |
| 6 | 2011 | 327 | |
| 7 | 2013 | 326 | |
| 8 | 2020 | 252 | |
| 9 | 2019 | 190 | |
| 10 | 2010 | 154 | |
| 11 | 2016 | 153 | |
| 12 | 2014 | 141 | |
| 13 | 2020 | 140 | |
| 14 | 2017 | 138 | |
| 15 | 2019 | 127 | |
| 16 | 2014 | 115 | |
| 17 | 2020 | 107 | |
| 18 | 2021 | 99 | |
| 19 | 2020 | 98 | |
| 20 | 2011 | 97 |
About Lin Shen
Lin Shen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 487 papers that have together received 15.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (100 papers), Colorectal Cancer Treatments and Studies (83 papers), Cancer Immunotherapy and Biomarkers (70 papers), Esophageal Cancer Research and Treatment (57 papers), Lung Cancer Treatments and Mutations (44 papers), Gastrointestinal Tumor Research and Treatment (41 papers), Pancreatic and Hepatic Oncology Research (33 papers) and HER2/EGFR in Cancer Research (29 papers). The work is most often cited by research in Gastroenterology (1.6k citations), Oncology (5.7k citations), Pulmonary and Respiratory Medicine (5.0k citations), Cancer Research (1.6k citations) and Surgery (3.1k citations). Lin Shen has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yoon‐Koo Kang, Atsushi Ohtsu, Hyun Cheol Chung, Yung‐Jue Bang, Eric Van Cutsem, Akira Sawaki, Taroh Satoh, A. Feyereislova, Michaela Lehle and Josef Rüschoff. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, BMC Cancer, Future Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.